Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Amneal Pharmaceuticals (AMRX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Amneal Pharmaceuticals is a member of the Medical sector. This group includes 961 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Amneal Pharmaceuticals is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for AMRX's full-year earnings has moved 8.9% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, AMRX has moved about 31.1% on a year-to-date basis. In comparison, Medical companies have returned an average of 2.6%. This means that Amneal Pharmaceuticals is outperforming the sector as a whole this year.
Another stock in the Medical sector, ANIXA BIOSCIENCES INC (ANIX), has outperformed the sector so far this year. The stock's year-to-date return is 46.1%.
For ANIXA BIOSCIENCES INC, the consensus EPS estimate for the current year has increased 7.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Amneal Pharmaceuticals belongs to the Medical - Drugs industry, a group that includes 147 individual companies and currently sits at #82 in the Zacks Industry Rank. On average, stocks in this group have gained 13% this year, meaning that AMRX is performing better in terms of year-to-date returns.
On the other hand, ANIXA BIOSCIENCES INC belongs to the Medical - Biomedical and Genetics industry. This 472-stock industry is currently ranked #73. The industry has moved +9% year to date.
Investors interested in the Medical sector may want to keep a close eye on Amneal Pharmaceuticals and ANIXA BIOSCIENCES INC as they attempt to continue their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMNEAL PHARMACEUTICALS, INC. (AMRX): Free Stock Analysis Report ANIXA BIOSCIENCES INC (ANIX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
